Eagle Bay Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-182
| Closed | -$15.7K | – | 688 |
|
|
2024
Q4 | $15.7K | Buy |
182
+36
| +25% | +$3.1K | 0.01% | 502 |
|
|
2024
Q3 | $17.4K | Buy |
146
+18
| +14% | +$2.14K | 0.01% | 659 |
|
|
2024
Q2 | $18.3K | Buy |
128
+30
| +31% | +$4.28K | 0.01% | 452 |
|
|
2024
Q1 | $12.7K | Sell |
98
-14
| -13% | -$1.81K | 0.01% | 523 |
|
|
2023
Q4 | $11.6K | Buy |
112
+12
| +12% | +$1.24K | 0.01% | 499 |
|
|
2023
Q3 | $9.09K | Buy |
100
+22
| +28% | +$2K | ﹤0.01% | 606 |
|
|
2023
Q2 | $6.31K | Buy |
+78
| New | +$6.31K | ﹤0.01% | 639 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$3K | – | 735 |
|
|
2021
Q4 | $3K | Sell |
50
-94
| -65% | -$5.64K | ﹤0.01% | 842 |
|
|
2021
Q3 | $6K | Buy |
+144
| New | +$6K | ﹤0.01% | 771 |
|